位置:首页 > 蛋白库 > FRBI_BLOB1
FRBI_BLOB1
ID   FRBI_BLOB1              Reviewed;       15639 AA.
AC   A0A0S6XHH0;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   17-FEB-2016, sequence version 1.
DT   03-AUG-2022, entry version 28.
DE   RecName: Full=FR901469 synthetase {ECO:0000303|PubMed:27660098};
DE            Short=NRPS frbI {ECO:0000303|PubMed:27660098};
DE            EC=6.3.2.- {ECO:0000305|PubMed:27660098};
DE   AltName: Full=FR901469 biosynthesis cluster protein I {ECO:0000303|PubMed:27660098};
DE   AltName: Full=Nonribosomal peptide synthetase frbI;
GN   Name=frbI {ECO:0000303|PubMed:27660098}; ORFNames=ANO11243_029940;
OS   Fungal sp. (strain No.11243).
OC   Eukaryota; Fungi.
OX   NCBI_TaxID=1603295;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=25838475; DOI=10.1128/genomea.00118-15;
RA   Matsui M., Yokoyama T., Nemoto K., Kumagai T., Terai G., Arita M.,
RA   Machida M., Shibata T.;
RT   "Genome sequence of fungal species No.11243, which produces the antifungal
RT   antibiotic FR901469.";
RL   Genome Announc. 3:0-0(2015).
RN   [2]
RP   BIOTECHNOLOGY.
RX   PubMed=11099224; DOI=10.7164/antibiotics.53.912;
RA   Fujie A., Iwamoto T., Muramatsu H., Okudaira T., Nitta K., Nakanishi T.,
RA   Sakamoto K., Hori Y., Hino M., Hashimoto S., Okuhara M.;
RT   "FR901469, a novel antifungal antibiotic from an unidentified fungus
RT   No.11243. I. Taxonomy, fermentation, isolation, physico-chemical properties
RT   and biological properties.";
RL   J. Antibiot. 53:912-919(2000).
RN   [3]
RP   BIOTECHNOLOGY.
RX   PubMed=11099225; DOI=10.7164/antibiotics.53.920;
RA   Fujie A., Iwamoto T., Muramatsu H., Okudaira T., Sato I., Furuta T.,
RA   Tsurumi Y., Hori Y., Hino M., Hashimoto S., Okuhara M.;
RT   "FR901469, a novel antifungal antibiotic from an unidentified fungus
RT   No.11243. II. In vitro and in vivo activities.";
RL   J. Antibiot. 53:920-927(2000).
RN   [4]
RP   FUNCTION, DOMAIN, INDUCTION, AND PATHWAY.
RX   PubMed=27660098; DOI=10.1016/j.jbiosc.2016.08.007;
RA   Matsui M., Yokoyama T., Nemoto K., Kumagai T., Terai G., Tamano K.,
RA   Machida M., Shibata T.;
RT   "Identification of a putative FR901469 biosynthesis gene cluster in fungal
RT   sp. No. 11243 and enhancement of the productivity by overexpressing the
RT   transcription factor gene frbF.";
RL   J. Biosci. Bioeng. 123:147-153(2017).
CC   -!- FUNCTION: Nonribosomal peptide synthetase; part of the gene cluster
CC       that mediates the biosynthesis of the antifungal antibiotic FR901469,
CC       an inhibitor of beta-1,3-glucansynthase, exerting antifungal activity
CC       against the pathogenes Candida albicans and Aspergillus fumigatus
CC       (PubMed:27660098). FR901469 is a cyclic depsipeptide containing 12
CC       amino acid residues and a fatty acid chain (PubMed:27660098). The NRPS
CC       frbI contains 12 modules responsible for the formation of the
CC       depsipeptide backbone which is denoted as Acyl-Thr-Ala-Tyr-Val-4OHPro-
CC       Thr-Thr-3OHPro-threo3OHGln-Gly-Thr-Orn-OH (C71H116N14O23) (Probable).
CC       The PKS frbB is probably involved in the production of the hydrocarbon
CC       chain, and the acyl-CoA ligase frbC might be involved in the transport
CC       of the chain to the peptide ptoduct of frbI (Probable). Because
CC       FR901469 contains 3 hydroxylated amino acid residues, the 3 oxygenases
CC       frbA, frbH, and frbJ might be participating in amino acid hydroxylation
CC       (Probable). As no thioesterase domains were detected in frbI or frbB,
CC       the thioesterases frbD and frbE may instead release and cyclize the
CC       products of the NRPS and PKS, respectively (Probable).
CC       {ECO:0000269|PubMed:27660098, ECO:0000305|PubMed:27660098}.
CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000305|PubMed:27660098}.
CC   -!- INDUCTION: Expression is positively regulated by the cluster-specific
CC       transcription factor frbF. {ECO:0000269|PubMed:27660098}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module. Each module is responsible for the recognition (via the A
CC       domain) and incorporation of a single amino acid into the growing
CC       peptide product. Thus, an NRP synthetase is generally composed of one
CC       or more modules and can terminate in a thioesterase domain (TE) that
CC       releases the newly synthesized peptide from the enzyme. Occasionally,
CC       epimerase (E) domains (responsible for L- to D-amino acid conversion)
CC       are present within the NRP synthetase. FrbI has the following
CC       architecture: T-C-A-T-E-C-A-T-E-C-A-T-C-A-T-C-A-T-C-A-T-E-C-A-T-C-A-T-
CC       C-A-T-C-A-T-C-A-T-E-C-A-T-C. {ECO:0000305|PubMed:27660098}.
CC   -!- BIOTECHNOLOGY: FR901469 inhibits the activity of 1,3-beta-glucan
CC       synthase from Candida albicans and Aspergillus fumigatus
CC       (PubMed:11099224, PubMed:11099225). With minimal inhibitory
CC       concentrations (MICs) against Candida albicans and Aspergillus
CC       fumigatus of 0.63 ug/ml and 0.16 ug/ml, repectively, FR901469 displays
CC       greater inhibitory activity than other 1,3-beta-glucan synthase
CC       inhibitors such as, WF11899A, echinocandin B, aculeacin A, and
CC       papulacandin B (PubMed:11099224, PubMed:11099225).
CC       {ECO:0000269|PubMed:11099224, ECO:0000269|PubMed:11099225}.
CC   -!- SIMILARITY: Belongs to the NRP synthetase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DF938583; GAM84991.1; -; Genomic_DNA.
DR   STRING; 1603295.A0A0S6XHH0; -.
DR   OrthoDB; 4243at2759; -.
DR   Proteomes; UP000054361; Unassembled WGS sequence.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   Gene3D; 1.10.1200.10; -; 13.
DR   Gene3D; 3.30.300.30; -; 12.
DR   Gene3D; 3.30.559.10; -; 17.
DR   Gene3D; 3.40.50.12780; -; 12.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   Pfam; PF00501; AMP-binding; 12.
DR   Pfam; PF00668; Condensation; 17.
DR   Pfam; PF00550; PP-binding; 13.
DR   SMART; SM00823; PKS_PP; 12.
DR   SUPFAM; SSF47336; SSF47336; 13.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 12.
DR   PROSITE; PS00455; AMP_BINDING; 12.
DR   PROSITE; PS50075; CARRIER; 13.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 8.
PE   1: Evidence at protein level;
KW   Ligase; Phosphopantetheine; Phosphoprotein; Reference proteome.
FT   CHAIN           1..15639
FT                   /note="FR901469 synthetase"
FT                   /id="PRO_0000454567"
FT   DOMAIN          5..81
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          1108..1184
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          2654..2730
FT                   /note="Carrier 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          4193..4269
FT                   /note="Carrier 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          5284..5360
FT                   /note="Carrier 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          6375..6451
FT                   /note="Carrier 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          7473..7546
FT                   /note="Carrier 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          9015..9091
FT                   /note="Carrier 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          10110..10186
FT                   /note="Carrier 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          11217..11293
FT                   /note="Carrier 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          12298..12374
FT                   /note="Carrier 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          13383..13459
FT                   /note="Carrier 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   DOMAIN          14916..14992
FT                   /note="Carrier 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:27660098"
FT   REGION          82..105
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          140..553
FT                   /note="Condensation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          579..971
FT                   /note="Adenylation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          1219..1626
FT                   /note="Epimerase 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          1667..2097
FT                   /note="Condensation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          2122..2518
FT                   /note="Adenylation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          2761..3176
FT                   /note="Epimerase 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          3215..3640
FT                   /note="Condensation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          3669..4059
FT                   /note="Adenylation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          4316..4714
FT                   /note="Condensation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          4756..5149
FT                   /note="Adenylation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          5402..5802
FT                   /note="Condensation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          5847..6238
FT                   /note="Adenylation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          6494..6889
FT                   /note="Condensation 6"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          6952..7335
FT                   /note="Adenylation 6"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          7580..7992
FT                   /note="Epimerase 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          8034..8459
FT                   /note="Condensation 7"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          8486..8882
FT                   /note="Adenylation 7"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          9136..9535
FT                   /note="Condensation 8"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          9583..9974
FT                   /note="Adenylation 8"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          10186..10208
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10240..10662
FT                   /note="Condensation 9"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          10683..11082
FT                   /note="Adenylation 9"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          11329..11725
FT                   /note="Condensation 10"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          11770..12165
FT                   /note="Adenylation 10"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          12418..12830
FT                   /note="Condensation 11"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          12861..13249
FT                   /note="Adenylation 11"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          13476..13901
FT                   /note="Epimerase 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          13940..14369
FT                   /note="Condensation 12"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          14390..14789
FT                   /note="Adenylation 12"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          15062..15433
FT                   /note="Condensation 13"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:27660098"
FT   REGION          15434..15511
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          15617..15639
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10187..10207
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        15434..15472
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        15497..15511
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         42
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         1145
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         2691
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         4230
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         5321
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         6412
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         7507
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         9052
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         10147
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         11254
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         12335
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         13420
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         14953
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   15639 AA;  1711325 MW;  EDFCE9379D8E28B0 CRC64;
     MASEHTSDGL RKLLLDLALE VLEIEPTRFR PEKSFLELGG DSLSAIEFMA KCRANDIDVD
     VGIILRAKNV ADLVDKIIEQ QLEEEEEDDD SLDNESERDH SQKDLMPSHL LELSDALLEK
     VIKPTNVEAD LRAAIHCISP CLSMQEGCLI SHAIDPEAYQ CRFVLKITST NPTNLFNAEN
     LAEAWRRVVA RHPSLRTSFM ESQNRPGKFD QIIWKSVRPQ ISICQDVSQV VAPTTPPKLD
     YSQPPHHLVL AQGSAADLYV RLDISHAIVD GQSTEVLLHD LWQAYQGRLP QGEAIAVTDI
     LKLHNSSTAA DAAAYWSDYL SKAQESYLPM KVNQAASTNL SSIKRTIKVA QDDLEAFCAK
     RGVTIANLCQ MAWGLVLRSF TNSDKVCFSY VTSGRQVPLV GINEAVGAFI TTLIQRLDFN
     RSKDIAEVLT QVNDDFIQSV PYQHLSFNDI GLKSARQWGN SILSMHRPLP TQVYANSGIG
     FEPITRTTAT DYDVSLNIDI FTDSIVLNMD FWLSKMSEED AHSTLKVYEK AILFVLNNSD
     KMTRDFLPLT EDDRATIHAR NQKIPSKVDK CVHDLVLETI SKQPDAVAVQ AWDGQWTYSE
     LNEKATRVAE FLISLGTGPE VKVGLCMEKS RWAPIAMLGI LKAGGVVVPM GTQHPLSRVQ
     TVLEDTKAIA ILTDKEQETR LGGLKVRKIT IDAEIMSNAN GSILANSTKV SPDNAAWIVY
     TSGSTGTPKG VVLEHAALCS SITGHSAAFQ LDNKTRTLQF AAHTFDAAIQ DVFTTIFVGG
     VICIPSEHDR MNALERVMDE LKVNFATLTS TVAGLLRPQA IPSMETIVLV GEAVKPAVVE
     AWLPHSRVLN AYGPSECSIH STCSKPITDK RDALVIGFPL TDCLWVTDPD NYNRLSPIGA
     SGELLIEGPI LARGYLNDLE KTGKAFVVDP DFVHELGLPK GRRMYRTGDL VRQNSDGSLT
     YLGRRDTQVK IHGQRVEIGE IEYHITRHSS VEEAVVVKVS GGPMDGRLVG AIVLKNFVSG
     TYHGTSVKEI DMGQHASAML QVSDVQLHLS ERVMQYMVPT FWIPVNSLPV NASGKIDRKV
     VGTWMADLDM DTVERLSGTG EEEEKEQTPA TAIEKELRRI WSETLNIPLR NISYRNSFLS
     LGGDSITAMQ VVSICRSVDI SVSVKQVLEC RALSELALVA RSTTESVDDL SVVPDGEFTL
     APIQQQYFDL VAADGLEARS SNRFNQSVHL SVRRPIGVAE LARSMEAVVA KHAMLRARFV
     PDTGSGWSQR IENQLVGSYR LKVSQVESME QVQSTIYDAQ DSLDLQNGPV FSADLISIKD
     QQLVSMTAHH LVVDLVSWRI IVRDLEQLLS DRTLQNTRSL SFPTWLQLQR DHTEEKISES
     TAALPFDVSP ADLKYWNLQP GTLTVKDRII EMIEVDELTT SLLFGAANNA MRSEPVEILL
     AALFHSFANT FIDRPVPAIF NEGHGREPWS DELDLADTVG WFTTMTPLQV TNTTGDIVDT
     LKQTKERRRR IPEKGMTAFA AQYFSGKSES QVMEILFNYE GRYQQLENED GLFRLAQPSD
     LGDADQSLSV GQDVKIQAAI DINASVSSKK LQLRIGFSKQ SRRQDDMKQW MVACGETITH
     LVKRLAHMAP MMTAGDFTTA TLTEDDVMFL EQTYLPEIGL NIPTDVEDVL PCTPIQQGIL
     FSQENSKSTY KVRQLVEVLP RDASRPVSVD QLVKAWRTVI RQHSIMRTIF VDSLPNQQRF
     HQVVLKEVDA VADIHILQNT QNRSLHDILA EQPEFDYRGK ERPPHRFTII TDISGKTFAH
     FEISHALVDA SSIELLVSDL FAAYGGMPSG KASHYGEYVA FLESKPITDD LIYWKSLLEG
     AEPCKLPLAS IDNATTTGSF TTRKHVGRQL TDLEELQTFR KEHEITIATL FQLAWSLVLK
     SRTGSSKVSF GYLSSGRDVP IRDVEGLVGP MVNLMICHNH LDQDESVIAA ARKIQTKFLD
     SFAHQRVPLD AIQHSLQLSG QALFNTTLSY KNSAASDSNA ASSISFNRLE AEDPTEYDIN
     IDITAGKTDI AVTLQYSPET LAQSSADELL QQLVEIVQML CHNTETSLGN LSLLTNNDVT
     SIKAWNAGPF LSDDRLLHHL IQEAAKEYTN ASAICAWDGE VTHDELNALT DRLAHHLRLE
     LGVGPEKTVG VCMDKSKWAV VSMLAILKAG GAVLPLGVQL PVARIEFLLR DASAVAVLAN
     QQHATRLRDV APKALVIDEQ LFSEIPELTG PACTDVKADS AAWVIYTSGS TGMPKGVVLQ
     HSALSTSLLA QGPALGITKG TRTLQFAAYT FDVSIGETFA TLIRGGTVCI PSEDRRVNNL
     AGTAADMRVN LAILTSTVAG LLEPAEVPLL STIVLAGEAA SPAVVDKWLG HAAVYNAYGP
     AECSVLASSS KPMARKEDAP VIGYPLSGCF WVADPTDYNS LVPIGVIGEL LVEGPQLARE
     YLGDEERTKT SFIQDPEFVT KLNLGHGHRM YRTGDLVQQN LDGSLIYIGR RDNQIKIRGQ
     RVEVGEIEYL VTSHPAVKDA VVILADKGLL KNKLIGVIAT HDSIKDGGYG SSVEIADEHH
     RQTASPYTAE IRRLLSQNIP AYMIPTLWVI LATIPINSSG KVDRAQIKQS LFTMDPKALG
     LVLASNTQDK LRTVPATALE KQLLTAWSKT LNLVPEQIGY GQAFTAVGGD SVTAMQVVSE
     LRKVGVTFSV RDVLQSQNIA ELALKAKSTT AHQAEETPYE PFALSPVQQM FFDDIAADGL
     VSAGEHRYNQ GFWLSVERPT GVDELARAIE ILVGRHAMLR ARFFHDGEHG WKQRIQEELQ
     GSYRFRAMQV ESDDDLAAIS NASQKSLDLE HGPVFSVDVV NRESQGQMMY VVAHHLVVDL
     VSWRIILREL EELLRNRTMS EQVPLSFRSW NHLQSQYSQG LSDVSATLPY SVPSADWSYW
     GLEQGYKAGD QIQKSVVLEE AITNKLFGDS NRALRTEPVE ILLAALFYSF QATFDNRPVP
     AIFNEGHGRE TWDESVDLSE TVGWFTIMTP LACAEEHSDI VDLLAQTKDQ RRRIPSRGLP
     YFTSRFLTEE GKRSFVDHRQ MEILFNYQGR YQQTESKDAL FRPIDLSNLT TKASAPAVGS
     LVKQTAVFDI DVSRAVDSTH VAFRFSQHIS RQDDIARWML KFQMSVTELL HRLEQMEIRV
     TSSDFPLTQL TRKDLMALQQ TSSSLPGLSS LDNIQDIYPC SPTQQGILIS QSKNPEGYQI
     RQFIKISGMG GKPVDIAVIK CAWQRVINRH SILRTIFIDW LPSQLSYHQL VLKGWTADVP
     IIACQDESAI KTHIKGLAEL KYGDNKLPHE FTLYQTETGE VYGFFQMSHT IVDAWSIDLI
     VRDLVAACDR EAKFMPAPRY GDYISYLKED TSDKDIKYWT KLLGNVEPCH LQIEGQDSKS
     ENESAFEIKS SIEDLTAFRG LQEKQGITSA SLLRFAWAVV LSAYTNSSQV DFGFLTHGRD
     VPVSGIENLA GPTINMSVCH LRIDSGSASL DGIKKSQDLF LEGLEHQRSS LADIQHHLKL
     SNQALFNTTM SYRQATSADA LKSSSIVIES VYAENPTEFD INVNIVAAQD RIDVELHYKL
     SAVSHTAAQR LLETLVHVAD QLARQTVAKL DDLIMMSPED LNKIRTRNAL VPSRLHSFVH
     ELVAEKTFTQ PHAPAVAAWD GDMTYQALDA VSQTLAGYLA SLGVGPETMV GVCMGKSKWA
     VVSMLAILKA GGTVVPLGVN APLSRIEHIV RDTAATIVLV DVAQADRLAT IASNIIDVND
     DLIDNLPACS TPPCAAISPD NAAYVIFTSG STGTPKGVIL EHGALCTSLR AHGKAFSLDA
     HSRVLQFAAH TFDAAIQDIF TTLAFGGCVC IVSEDERMNN LAAGMRRTGV NFAALTSSVA
     ALIHPDDTPD LKTIILVGEA VSEVVVKRWI QSSRLINAYG PAEGSICTTC TAPMRSDFEA
     SNIGYPVAGC VWVTDPADYN RLCPPGVPGE LLIEGPLLAR GYLNDAEKTA AAFVREPKFL
     KQIGISNRTG RLYRTGDLVR QNPDGSLTFM GRIDSQIKIA GQRVETGEIE NQIARLLPTV
     RQVSVDLIQD PSRSGARTLV AAIEIHTNDT KPSQQSLEPV KYSRGLHKQI EALQDSLAEV
     LPSYMVPKIF VPLVTLPVGA TGKLDRRALK QYLESLDNSE LRAFVANEAV KEPPSNDAER
     MVQSLWAKIF KRPTSAIGIN DHFFHLGGDS VLAMQMIAAA HEEAMDLTVA DIFRMPRLHQ
     LAAIVTQRGF KAESSESMNP APFNLAQHLL SSVSEERDRQ FAELAEQCSI GVEDIEDVYP
     CTPLQENLIA STLHNAEAYI ARRVFRLRPE VATDRFMSTW TQLSEMQPIL RTRILFTTLL
     QPVQVVVRKS VSWNTAESLQ QYLDTDRKQP IGEGEALCRL ALIDEGDRYF VWTMHHSIYD
     GWSTSKMLEV LSNLLEEKPV SPAVPFSRFV KYVAVQDAET TQNFWRQQLD GVVSATRFPA
     LPSASYKPRP TKKASLTLTA TRQPGQVTTS IALRAAWAKL VATYTNTDDL VIIEALSGRN
     APVSGILDIL APTVTTVPVR VRLQPQQTIR KVLADLQQQS ADMIPFEQTG LQNIKRIAPG
     AGSDLGSEHL FVVQTALEQA SKDNTGPFDR VLDADVPLDY ALLMECTMDL TRDTVDVQAS
     FDEAVMSADQ IEMMLFHFQQ IFEQILAHGT GLEEETEKGE TMGGIDLLSK QDMDLIGSWN
     AKPYQALDAC LPAQVTEAAS TRPDAQAVCA WDGAMTYAEL EQQAGRLAHY LSGRNVGPEI
     KVGVCMAKSK WAVVSMLAVL KAGGVVVPLG ADHPLLRIQH MIRDTGMDLI LVDSAQAERL
     ASTGPDLVIV SEVFVDSSLG QETFSRESIN PESAAWIVYT SGSTGTPKGV VLTHKSLCTS
     IKAHGTAYGT SSGTRMLQFA AHTFDAAIQE VFTTLIFGGC VCIPSGDDRV NDLIRVICDM
     DVSLAALTPS VAGMILPSSV PSLKTLILIG EAVTSAVLSK WIGAITVFNG YGPTECSIYT
     TCKRMESVKD LGNIGSPLGG RVWVTNVTNY HQLCPVGAPG ELLVEGPILA REYLNDTPRS
     SASFVENPGF VKRFGLEGQR MYRTGDLVRQ NLDGSITILG RLDTQAKLRG QRLEATEIEN
     HIIQSQSGIQ SSVVSIVQLE GATTEPVLVA AIEFSSGSEF TKQEKQNDGL IESSDVLRAW
     FQKTQESLYQ TLPAYMVPKI YIAMERLPLN TSGKLDRPKV RQLIESLHSD TLASYSSAGS
     NTVEPATIME RQLQKLWASV LNKPQASVGA DDHFFQIGGD SVVAMRLVAS ARQEQIHLSV
     AQIFKHPRLC DLASHIDHHT LLEETGDLAP FALWLGEDQA ESRSSAMQKL ASQCDVAVEQ
     IEDIYPCTPL QEGMMALTMQ NPRAYVFQSV FRLDDTLQSE RLVAAWDKLV DIVPILRTRI
     VALADSRSLQ CVIREPVQWK KSNSLKDYLR QDSQDIIKSG SRMSRCALIE GEKSERYFVW
     TAHHGLYDGW SRMRMMELLS KIYNSETLPT LPPMSRFLSY LGGSSQADMK TFWQNQLANL
     AVAKFPALPH ATYQPNVDCI AKRQLIGQPA NSSVTTSVAL RAAWAITVAT YTSSEEALLA
     VALSGRTAPV EGILDLLAPT ITTVPVRIRI PHSRTVRELL EEVQKQATDM IPYEHAGLQN
     MPQLVDDSSV LASLGHLFIV QSTLDGVSVR GHVAPEKTLG LHAEEANFTG LDSYALNVEC
     TMLNEDKIHV DARFDKNVVS EKQVERVLDS FATVFAQLCD SSAAETLVQD VVVIGEKDAQ
     AIRAENAVVT PTHERCIHDL VMDSTLKYPN EPAVHAWDGG FTYQQLDAAA TRLALYLSQQ
     GVGPEVKVGF CMDKSKWAVV SILAILKAGG AVTPLGVQHP LPHIEKILSS TKATIILADA
     QQASRLSGLA AKSVVVDGKL LESLPGSVSG QTVCKVVTPD NTAWVIHTSG STGTPKGVLL
     HHSQLSTSFK HQTVAFGIGQ DTRTFQFSAF TFDVSISDVC LTLYVGGCVC LPSESDRMND
     LEKTARDMEV NLLMITSTVA GLIQPTNVPS AKTLVLTGEA IAPNVVTQWL GHATILNAYG
     PAECSVDSCS VAFTSPAMAS NIGYTTAACF WVVDQLNPHR LVPVGTIGEL LIEGPLVSHG
     YLNDPEKTSQ SQMVGPAFFK QLGLEQSRGR IYRTGDLVRQ NADGSYEYLG RRDSQMKVHG
     QRVEAAMIEE LIVRLLPDAH VSLVDLVLFG DGKADSTLVA SIEFKTDSIY QQHVTSSGLL
     AATDELREAL YHVRTSLADS IPIYMVPSVF VPFARLPTNM SGKLDRKALQ QIYKTLGQEE
     LDLYAPQAGE AAGAQPSTTA EIKLQALWAT VLRKPSAQYS TRDHFFQSGG DSVSAMRLVA
     AARQEGLQLA VTDIFNNPRL EDMAKIVEEH VEEEELVDVA PFSLWEADIP TPEQRKSELA
     DLAAQCKVAT DNIEDVYPAT PLQEGMMAIT MQSPRAYVSQ VVYRLDKEMD LDRLIRTWQR
     AEQIAPILRT RIVARPEAAS VQVVIREQSE WSFGNDLEAY LAQDKKSPVT FGGPLSRFAL
     ITSKQKSERY FVWTCHHSLY DGWSRNRIMD AVARAYTGEE VGPSTPVTRF LQHLGNAGEA
     ETSKFWNTQL DGLTATKFPA LPHSGYQPYV KSVVSQRVRD TSINGVVTTS VLLRAAWAIV
     VAAQTGNKDV LLTVSLSGRT VPVPGILDML APTLTTVPVR LRVEREQTIA AFLREAQKQA
     TDMMPFEHTG LQGIRRLLPK NAAPLDPGHL FVVQTSLDKD DGSGSDTFGL TPMDPEIDGF
     DSYALNISCT VLEDEQQVEI EARFDEQVLS QGRTTALLER FAKVYQQLSH LATANAGAGA
     CVGDISTLCQ SDIAQLKDWS ARASYDKAEH CLHTLVHEAT IKYATSTAIE AWDGSMTYAE
     LESAADRLAQ HLASLDVGPE TMVGMCMDKS KFAAVAFFAI LKAGGVCVPL GVQHPVSRVE
     HIVQDAGATV LLVDKQQAER LNDMESDAKV ITVEEDFLSR LPQSNGFVCH NVTPDNAAWI
     IYTSGSTGTP KGVVLQHSAI VSAMLGHNAA FGLNSKSRVL QFAAHTFDLL ISEIFSTLLC
     GGTICIPSEE TRVSNLAQTA KAMGVNFTWL TSTVASMLTP QELPDLKTLI LIGEAASAAV
     VETWLGHATV LNAYGPSECS IHSSCSKSMV KKEDTPVIGF PVCGNFWVVD AEDYHRLAPV
     GGVGELLIQG PHLAREYLKD EAKTAAAFVN NARWASELGI THSTQKMYRT GDLVQQNPDG
     SLTYLGRRDT QIKIRGQRVE VGEIEHHITQ HPAVWHAAIV RPSTGPLAGR LAAVVVLHHS
     AAGNGYSSDV LPLEAELQMA NAVTQEVQSF LTERVMQYMV PSTWIPVAAL PMNLNRKTDL
     GRLTRWVAEL DEKALTAYQT EAEDDELVSA RGTAMEEQLR TVFSRILNVS ESRTRLDRSF
     LSLGGDSVTA MQVVAQCRRL GIQLSVRDVI QSKSISQLAL LASTDESEVA HDAVSYEPFA
     LAPIQQMFFD QVASDGMNVM GENRYNQSVC VRLNQAIELS SLQAALDAVV DKHAMLRARF
     QVDKQSWTQR ILETVQGSYR FQTVTAGSED EIFDILETAE SALDIENGPV FSVTVINAPG
     RQLVFLVAHH LVIDLMSWRI ILTDLAELLQ NGGQDGKYTL DRSLSFPQWS RLQAEYSHTI
     KSLDSVLPFD VPAADWAYWG LSAGDFVTRD KIHEHVEISK QITELLLGEG ANSALKTEPV
     ELLLAALFQS FHKTFPNRLV PAIVNEGHGR EPWDSSVDLS ETVGWFTTMT PLHVPVDSQS
     YDVVETLKQT KERRRQTPGR GLPYFTARYL TKEGRTKFAD HQMMEILFNY QGQYQQLERD
     DTLFSLETLG GRGQPSRVGQ NVRELAVFDV AVTVSQGPLH VSIGFSKNIR RPKAVQDWLT
     AYSKTLEELT TQLVSLAPTR TSSDFPLASL SQQDIDAIAT ENLSSTGLGF NDVEDVFPAS
     PMQQGILLSM SKNPGTYYVQ QTCEFIPKAD VKYDTARLAS AWQLVVDRHA ILRTFFTDAL
     PDQHAYHQIV LSAWTADVQI VKCAHQTEVQ SQIGARAQQA FAADQPPHRF TVYEVGDESL
     YGHFEISHAL VDASSVQLLV HDLLRAYDGS LPAAQGPRYS SYISYLQERS PEEDLKYWTS
     VLGDVEPCQV KTVTFGPAQP IDERPQNIAA EIENLEILQR FGEAHGVTLA TLFQLAWAMV
     LGRHTGLQQV CFGYLLNGRD VPVAGIEEMV GPMINMMVCA VSLDNKELAV PEAAQLVQKQ
     FLEGFEHQRT SLGDIQHAFK LSGQALFNSV LNYKAAQSTD GAQTTSLSIA GKGSEDPTEY
     DISVNVTKTT DRISLSLQYA QAEVSPALAQ RLLDGLLQAV HTLAGSDASQ RMRNISLASV
     KDVAKFREWN THTPPRVEST VHALVQKSVH ARPDATAICA WDGEMSYGEL DAAASRLASR
     LVDDHGIGPE AKVGLCMDKS KWVVVAMLAI LKAGGAVLPL GVQHPLERIA HIVRETEAKV
     VLVDEGQEKR LAEMDVSTLV VDEALVAGVS DALDSKTQTS SPDNTAWIIY TSGSTGTPKG
     VVLQHGALAT SLLAHSKAFG MGVHTRSLQF AAHTFDASIQ DTMTTLTIGG CICIPSETER
     MNSLSAAVAR MGANCANLTT TVVGLLHPSE VPSLKTIIFG GEAVLPSLVD LWAPHATLIN
     SLGHTECSIN SSFSQPMTHG WQAPGIGKAI CGSFWVADQV DFNQLVSIGS VGELLIESPQ
     LAKEYLRDSA KTAAAFVTDP DFVHQLGFTK GRRMYRTGDL VRQLEDGTLT YVGRRDTQVK
     IRGQRVEIGE IESTVLAVLP EVRSVVVNLI KRGDSQQTLS VAVEFVAENT FLEGEVNTDT
     GLIAPSKELL EAFGLLRDRL TEVLPLYMVP SIFVPLVKLP LNASGKLDRR ATQQLVESLD
     DATIAAYSSS AAKVQPATDA ERQLQTLWAG VLDKDVNAIG ATDHFFQLGG DSVVAMRLVA
     AARQENVQIS VADIFAHPRL RDLAKTIQDS ETADEEGDAA PFALWEESLD MANSQQRQQE
     LIKLANECAV EVDQIEDVYP CTPLQEGFMA LTMQNPRAYV FQSCFELDSK IGTDTLISAW
     EQLMDVVAIL RTRIVALPDS QSLQCVVREK LPWTFSNKSL DDFLASDNQT PMTSGSRLCR
     CAIVEEPQDN KRYFVWTVHH GVYDGYSRSR MLELLTKILT GHSLPPLTPI PRFLQYLARV
     DDDEAAAGRF WKAQLANVAA PKFPALPHAA YQPRVDSTAR MQIAGPRLAA SSGVTTAVAI
     RTAWAIAVGA HTNSDEALLV VALSGRAAPV DGILDLLGPT LTTVPFRVRI DREKTLSELL
     TQVQSQASDM IPFEHTGLQK VQVLAGSGPL ELGHLLTVQS TLSDERDDPV EALGMHAREV
     SNLGSDSYAL NVECSIWNVE NKINVEARFD GNVISQDQVE AILDGFAAIF RQLCDENIAA
     RTKVSEVSVI GEKGLELLRA RTDKMPAPYE VLVQNMVTNS LIKNPHAIAV NAWDGDLTYQ
     QLDDAASCLA HHLVRSFGIK PEDKVAFCMD KSKRAVISML AILKAGGAVT PLGVTHPLQH
     VQRVINNASS PLVLVDKKQA ERFAELSVPT ITIDDELLDN LPAYSGPACS SLTVNNTAWV
     IHTSGSTGIP KGVLLHHSLI ATSAKYQAIL YGCVGPHTRT LQFAAHTFDM NIFEVFLTLY
     GGGTICILSE EDRMNDLERQ ANAMKVTLAF LTSTVAGLLD PTKLPSLHTI VLTGEACTPS
     VVQQWLDHAV VLNAYGPAEG SVASITKAYT HAEEYSNIGF ETAGCFWVVD QLNSDRLVPL
     GTIGELIIEG PLVSPGYLND AEKTAQMFIV DPAWVTDLGP TRGRRMYKTG DLVRQNQDGS
     FEYLGRRDNQ MKIRGQRVEA AEVESAIVRL LSGVRTAAVD LVKVGNDADK QVTLVGAFEF
     VPGTEFTTQG EAEGGLLAPS QPLREALQTL RKDLLQGLPP YMVPSIFVPL VRLPQNLSGK
     LDRRALRQML EGLDGTQLTS YASEDSERIE PATPMEMQLA KLWATVLRKP VESVSASDDF
     FQSGGDSVAA MRLVAAGRQE DVDFTVADIF REPRLSGLAA LIQKQIDEEE EYDDSEEEEE
     DDEEEVREVK GDVAPFALWK EEDGAIADLA AQCGVAISEV EDVYPCTPLQ EGLMAITMQS
     PHAYVSQAVF KLGQDLDIAR FKAAWQKTTE KVSILRTRIL ACRDSASLQV VLRQPIEWKS
     SGKTLHAYLA DDKDTPMTLG APLCRLAIVE NNNERHFVWT CHHSLYDGWS RHRTMDLVSR
     IYAGSEVGSI TPMARFVNHL VKVREVDDTR QYWNAQLRGV TATKFPALPN ATYQPLVSTV
     LRQKMSFTPL PGTITTAVML RVAWAMVCAA QTSNSDVLLA VSMSGRTIPV PGILDMLGPT
     LTTVPVRISI DRDEGLHTFL KAAQRQATEM MPYEHTGLQA IRRLLPDGGA KVDLDAGHVF
     IVQTSLDKTA DSVTRPFGSA LEPIDINQHG FDSYALNVSC TANDDEQEVE VEVRFDNKVI
     SEYQMQSVLD RLATVLQQIG HLGQAAKVAD LQVLSETDKT KIKAWNGICP PRIESCVHML
     THKQAIERPN APAICAWDGD MTQRELDAAA DRLAGHLASL GVGPEVKVGM CINKSKWAVV
     CMLAILKAGG AVLPLGVQHP IPRIQHILRD TAADVILVDE EQVERLGSLG SETRLVTVDE
     RLVSSLPQPA APVCSTVGPE NAAWVIYTSG STGVPKGVVL QHFALCTSLV AHGTAFGMGS
     DTRSLQFAAY TFDASIQDTM TTLVNGGGCI CIPSEDERMN SLAAAIRRMK VNCATLTSTV
     AGLLDPTEIP LLKTIAFGGE AVGPAVVERW GKYANLLNSY GATECSINSS CSKPMTEAHH
     AANIGWAIPN SGVFWVVDSV DFNRLAPIGA VGELLIEGPQ LAREYLNDPV KTASSFVVDP
     SFIAQLNLGS GRRMYRTGDL VQQQEDGSLI YLGRRDTQIK IRGQRVETGE IESAVRRFLP
     DVRAAVVNLV QRGGDNALRV LTLAVEFIAE SSFQTGETSS TDLLAPSQAL REAFADLRDK
     LLEILPPYMV PSIFVPFVKL PVNTSGKTDR RAVKELIEAL TEDALAAYTT TSLTKTEPAT
     GMERHLQALW ASVLNKPIES VGANDHFFQS GGDSVVAMRL VAAARQKDIH LTVKDIFSFP
     RLSDLARETE SQGAAEEEDV APFALWEQSG SNAIDEIARL CAVSSDGIED VYPCTPLQEG
     LMAITLQHTN AYVSQRVFKL DASIDVAQFK NRWDSLVELL PILRTRIVPA SLSSSLQVVV
     REAVQWQTAS SVEEYLRRDQ NTPMTHGGAL CRLALITEQD GTNTFVWTIH HSIYDGWSVI
     KMMGMLDGLS REQTLPEVVP VSRFVKYLTQ QDPAASESFW KQQLEGANLT PFPALADTTY
     KPRPTNRVRF QFSKLKRHGS VVAPAILRAA WAITVATYSG TDDVTLTVAL SGRNAPVPGI
     TDIVAPTVTS VPVRIAIQQD QPVAAYLSAI QQQAVDMIPF EHTGLQNIKR IALPAGASFG
     SGHLFIVQAS VDNDRAAATQ FSGMTEQFSD QDINMDYPLI VECTTDPEQA MVEVSVSFDN
     AVLSPDMVDG MMHGFETIFQ QLSSVNEQDG TDNSVKISDV QLLGRKDSEM IQSWNKTLVP
     RATDCLHHTF KRTADKQPER PAICAWDGNF TFHELNQTAD RLAAHLIARG VGAEVMVGVC
     MNKSKWAVVG MLAILKAGGV VVPLGVQHPL ARIEHIVKDA DIRVVLVDSQ QGQRLGDNLA
     EKIVVDDALL TSLPNPASVK DVRVTADSAA WVIYTSGSTG TPKGVVLEHG SLATSIQAQA
     AAFGITPETR ALQFSAYTFD ISIQDMFATL LHGGCVCIPS EEARVVGLAG AIPELKVNSA
     ALTSTVTALL DPAEVPDLKT ICFVGEAVNQ SVMDKWVHHC SLINAYGPAE ASICTTFNQI
     KKGDAASTIG TPLAGRVWVV DPTNFNRLVP VGAPGELLIE GPLLARHYLN DPIKTEKAFV
     QAPSFTPHFG ISAGTRMYRT GDLVRQNAIG SLTYIGRRDT QIKVRGQRVE IGEIESLVKR
     LLPSAHTAVV DLITRKEGSE ALTVAIEFAA GQPASVANPS GSPLSSPTTA LREELSNLRA
     ALFEALPSYM VPSVFVPVVK LPVNASGKLD RGAVRRLLQD LDDEQLGAYV SAEAERKEPS
     TEMERRIQQL WSAVLKKPAT AIGANDHFFQ SGGDSVSAIR MIASARGMDV HLTVADVFKH
     PRLSDLAAAV QGRITDEDEE DPAPFTLWQE SSVDDIAEHK AKMHDLASQC DLTAEQIEDV
     YPATPLQEGL MAITMHSPEA YVSQAVFRLE DNIQVDQLIA AWESLVQMAP ILRTRIVSQP
     GQSSLQIVVK ERTSWIRQTS LNIYLAEDKK LPIVSGGELS RTAVVEDKSK RYFVWTCHHS
     IYDGWSRRKM MDLLARIYND EVVEGLTPIP RFIRYLTQVS RQDTETFWRA QLEGVAVSKF
     PTLPHPTYQP RTSSMVRKTF SNASSANVAT MSAVLRAAWT LVVNAHTGTD DVLLAVSLSG
     RTLPVPGILD LIAPTLTTVP VRNKIDRNQS ITSFLEQVQS QATAMMPFEH SGLQQIRRML
     PGSGTDLDPG HLFMVQTNLD QEDVGAVSDI GLRFEETGVE GFDSYALNIL CTTSDGAHGT
     EVEARFDDKV ISHARVEALL NRFDHVFAQL VTETTASQKR IQDIEMVSEQ DVAQMRSWNT
     AASLQPVGMC VHDLIRDSFS SRADEIAICA CDGDLTYGEL DDASTRLAQY LVSLGVKPEV
     KVGMSMDKSK WGPIAMLAIL KAGGVVVPLN VAHPVMRIEG IVKDTEMTIA VLDAGQADRI
     GHLVSNAVVL DAAFLDSLPQ VNSRFSTTVT PENAAWIIYT SGSTGTPKGV VLQHSALSTS
     LKAHGAAFGM NSSTRTLQFA ANSFDATISE FFATLLYGGT VCIPSEDDRM SDLTNICNSM
     KVTLAMLTST VAALLGDIPT LKTLILVGEA ASPAVVEQWL SRATILNAYG PSECSIHASC
     SKPMAAKEDT PIIGYALSGC FWVVDPTDHN RLAPLGGTGE LLIEGPQLAR EYLNDSAKTS
     SAFVVDPAFI TKLGLGTGRR MYRTGDLVQQ REDGSLVYLG RRDTQIKIRG QRVETGEIEH
     HIAQHSAVLR GAIVRPKTGP LAERLVAFVV LNELAVGSGY SSEVLEISAE DRTHANEVAT
     GVKKYLSDRV MQYMVPGVWI TLAALPMNIN SKTDLLTLTR WAAEVDDETV ATYTNEDTQT
     ASMPGTVQEE QLRSIFSLVL NIPEVRIPLD RSFLSLGGDS VTAMQVISQC RKQGITLTVR
     DVIQSQSIQQ LGQKVKEAVD DNEELNKVSY KPFGLAPIQQ MFFEQIVPKQ GSGDGENRYN
     QSVFLKLQQR YALEVIRRAV DAIVDKHAML RSRFERTADG LWTQRVAQKL DASYSFHNQS
     VESEDEIYAI LDTAEKSLNI ENGPVFATRI IDTSDKQLLF LVAHHLVIDL MSWRIILNDF
     AEALQGRSLA ASRSVSFEAW AKAQNEYSKT LQIEKVLPYT VPMADWNYWG VPIGSYLPAD
     KVYQTIDVDE KTAALILGDS NTALQTEPVE ILLAALFHSF RRTFLDREVP AIVNEGHGRE
     PWDDSIDLSE TVGWFTTMTP LHVAVEKDDL IKTLRGTKEH RRQTPGRGLP YFTSRYMTEQ
     GREAFAHHRA IEVLFNYQGR YQQLERQDAV FSLESLARGV PSPVGANVPE LALFDVSVTA
     LASTMQISIG YSRNIRDSAL VHEWATNYGN TLKDMTSTLL QMAPTRTPSD FPLATLTDAD
     LSTIEKKNLV PASLVYANVE DILPCSPIQQ GILLGQVKAP STYHIQQTCR FRPKSKHTLE
     TDVKRLSRAW QRVVQRHSIL RTFFVDSLAS HDSFHQVVLS SWSADVTVVN CTTADEAKAY
     FATHNPFAAN QPPHRFTLVC VGGSDLYGHF EISHALVDAS SIELIVNDLL QAYDDKLTVA
     PGPRYSSYVA HLQKSSAEAD LGYWTALLQD AQPCHVRDAP KDLQNVDNTL NKLTSQMTDV
     ATLQRFSEIN GVTLATVFQL GWAMVLSSYT NLPQVCFGYL TNGRDVPLAQ VDEMVGPMIN
     MMVCTIKLDG ETAVSEAAKH AQQSFLEGFD HQRTSLAAIH HALHLSGQPL FNSALSYKRE
     QTVSGQQKPA SLALESVASE DPTEYDVSLD VNWSEHSIGL SLVHTRQLSS GLAKSLLDSL
     VHVVTQLVRG DRTSKLRDIS IVGEHDLQQI KAWNTIVPSR MDATLHTLVR DAAHRTPDAL
     AVHAWDGDYT HVELDSTVQR LATRLRALGV RPETRVAFCM DKSRFAPVAV LAILNAGGAV
     VPLGVQHPVD RVNKIVLDAE AQVMLVDATQ AARLVGVVPN MIVVDDKFLH NLPNVDSEQS
     QPTITPDNAA WVMYTSGSTG VPKGVVLPHG ALATSLMVNG KSFGMGPHTR TLQFASYTFD
     DSIHDIIATL SFGGCICVPS ETQRMNSLAE AITSMRANTA AITPTVASLL DPKAVPTLKT
     VLVGGEAATP QVIELWGPHA TLLNLYGPTE CSINACVSGP MTIAAHAASI GRPISGSGLV
     WVVDPANPNA LVPLGAPGEL LLEGPQLARE YLNDPAKTSA AFILDPAFLK LLGIEDTGRR
     MYRTGDLVIQ RADGSLDYLG RGDGQIKIRG QRVETGDIEA AVRRLMPAAR GAVVDLLARG
     EQRMLIAAVE LVDGERADDG VLLAPSSEIR EAFSSLKTAL RNVLPPYMVP QSFVPLARLP
     VNASGKLDRR AVTTILSGLT SDVLASYTSD QGDSQLPASA DEGALAGAWA RVLGVEQSSI
     TRNDDLFHLG GDSISAMKLV QAARELDLHL SVADIFRNPR LADMASVASA ARTTQGEEQQ
     YERFSLVETD KTALLAELPA LLKVEESTIH DALPVTDFQA LCVAGNTIGS GLEMNYFALD
     GQHAVDLAAL KQGCKDLIQQ TEMLRTVFVF HQEQMLQVVL AMSNPPVTLH ETDEPLDTFT
     QQLIERQTSQ PIRLGQPMAS IDIVASPSSA THRIIFRLSH ALYEGVALPM IFQRLSTLLA
     GQALTQGPSF GAFVADLQSR ATQEAYSHWR SLLQGAQMPR LSSPPQEQRL FRMAPLPARS
     VPLPASVQKG ITPAMLVKAS WAAVLARHTR TPDVVFAETV SGRASASPDV ADVLGCCAAI
     LPVRATIRPD TTTAELLASV REQQILSAQN DALGARSIIR NCTEWEKGTR FTSRINHTLA
     EDGAVALGEE EYKLSPLPPR EWMDVAEVSI ASFQFGDRVE VGMSFADDEL ERGVVEGLLR
     ELCDIMVRLA SQQEGTVWDS EERSDSLLPS ASAVNGTNGS NGDGTDAANG IGQKTGGTGG
     HAVEKSSGDA EVEKVSTNGH ADNNTSAENR QSELSAAIKH ATGTVLKNKL KTERSTEALW
     SGHADVVDYA HVAFLLQRQG WSVLTEDLVR CRSETELIDV VVKREAERVK GNGSAFNGAN
     GHYSNEESVN GNGLHGVQTN GHAGKGVTNG VNGGSKGHI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024